<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="163146">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01935596</url>
  </required_header>
  <id_info>
    <org_study_id>PI09 - Pr. DUPONT/LAIGLE</org_study_id>
    <nct_id>NCT01935596</nct_id>
  </id_info>
  <brief_title>Comparative Study of the Effects of Two Local Anesthetics Administered Intrathecally: 0.5% Levobupivacaine and Ropivacaine 0.5%</brief_title>
  <acronym>ROPI-LEVO</acronym>
  <official_title>Comparative Study of the Effects of Two Local Anesthetics Administered Intrathecally: 0.5% Levobupivacaine and Ropivacaine 0.5%</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <authority>FRANCE : Agence National de sécurité du médicament et des produits de santé (Saint Denis)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a Biomedical Research, prospective, randomized, double blind, controlled
      monocentric, phase IV comparison of the effects of two local anesthetics intrathecally: 0.5%
      levobupivacaine and ropivacaine 0.5%.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Progress in the practice of anesthesia led to a safety requirement of growing in daily
      practice. Spinal anesthesia commonly used technique for surgery of the lower limbs, provides
      a triple neurological lock (sensory, motor and autonomic) of roots of the spinal cord by
      intrathecal injection of a local anesthetic agent, following the rules of and strict aseptic
      conditions.

      Levobupivacaine and ropivacaine local anesthetic agents are considered less toxic and tend
      to replace the use of bupivacaine, reference molecule, but the plasma transition is
      extremely toxic to patients. However, there is currently no study comparing the benefits of
      levobupivacaine and ropivacaine in isobaric form injected intrathecally for trauma surgery
      of the lower limbs. We propose to conduct a prospective, randomized double-blind comparison
      of the use of these two molecules in spinal isobaric form by evaluating the time and
      duration of action (sensory and motor block), hemodynamic and ventilatory changes
      (sympathetic block), and the occurrence of any adverse events.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>duration of anesthesia on sensitivity</measure>
    <time_frame>during 6h after induction</time_frame>
    <safety_issue>No</safety_issue>
    <description>Thermo-algesic exploration of sensitivity through the application of an ice cube</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of anesthesia on motor block</measure>
    <time_frame>during 6h after induction</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Patients Undergoing Lower Limb Surgery</condition>
  <arm_group>
    <arm_group_label>ropivacaïne 0,5%,</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>intrathecal administration of 15mg of ropivacaine 0.5%.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>lévobupivacaïne 0,5%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>intrathecal administration of 15mg of levobupivacaine 0.5%</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ropivacaïne</intervention_name>
    <description>spinal anesthesia.</description>
    <arm_group_label>ropivacaïne 0,5%,</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lévobupivacaïne</intervention_name>
    <arm_group_label>lévobupivacaïne 0,5%</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient admitted to the emergency for lower limb trauma,

          -  age over 18 years and below 65 years

          -  lower limb trauma surgery can be performed under spinal anesthesia.

        Exclusion Criteria:

          -  Refusal of patients to participate in the study,

          -  Patient with cons-indication to spinal anesthesia:

               -  Local anesthetic allergy agents (1/13000)

               -  bleeding disorders, including pharmacological origin

               -  infection at the puncture site,

               -  refusal of spinal anesthesia by the patient,

          -  Patient trust,

          -  Patients whose coagulation is abnormal.

          -  Patients with cognitive impairment or incapacitated adult,

          -  Multiple trauma,

          -  Porphyria,

          -  Central preexisting neuropathy,

          -  A history of spinal surgery,

          -  Epilepsy uncontrolled by treatment,

          -  Hypovolemia,

          -  Pregnant or lactating women,

          -  Participation in another ongoing clinical trial,

          -  Patient on anticoagulant therapy,

          -  Patient not affiliated with a social security system.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hervé DUPONT, Professor</last_name>
    <role>Study Director</role>
    <affiliation>CHU Amiens France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hervé DUPONT, Professor</last_name>
    <phone>+333 226 683 75</phone>
    <email>dupont.hervé@chu-amiens.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christophe LAIGLE, Doctor</last_name>
    <email>laigle.christophe@chu-amiens.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hervé DUPONT</name>
      <address>
        <city>Amiens</city>
        <state>Picardie</state>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hervé DUPONT, Professor</last_name>
      <phone>+333 226 683 75</phone>
      <email>dupont.hervé@chu-amiens.fr</email>
    </contact>
    <contact_backup>
      <last_name>christophe LAIGLE, Doctor</last_name>
      <phone>+333 226 683 75</phone>
      <email>dupont.hervé@chu-amiens.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>September 4, 2013</lastchanged_date>
  <firstreceived_date>August 23, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Anesthesia</keyword>
  <keyword>Randomized study</keyword>
  <keyword>Lower limbs surgery</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics, Local</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
